Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Targacept Inc

+ Add to Watchlist


2.6100 USD 0.0200 0.76%

As of 17:20:00 ET on 03/03/2015.

Company Profile for Targacept Inc (TRGT)

Targacept Inc. is a a biopharmaceutical company engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting neuronal nicotinic acetylcholine receptors.

Contact Information

Targacept Inc

200 East First Street
Suite 300
Winston-Salem, NC 27101
United States
Phone: 1-336-480-2100
Fax: 1-336-480-2107

Key Executives for Targacept Inc (TRGT)

Stephen Anthony Hill "Steve"President/CEOMauri K HodgesInterim VP:Finance/Interim CFO
Patrick C RockSenior VP/Secy/General CounselSteven M TolerVP:Clinical Pharmaceutical Sciences

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil